University of Florida College of Medicine Assistant Professor, Dr. Andrew Bryant, has been named a recipient of the Pulmonary Hypertension Accelerated Bayer (PHAB) Awards at CHEST Annual Meeting 2019. To learn more about this award, click on the press release below.
2018 Lung Transplant Program Review The UF Health Lung Transplant program finished calendar year 2018 with its most successful year in history. While maintaining quality outcomes above the national average in all categories reported by SRTR, the Transplant program performed 70 transplants (66 adult and 4…
Please join our team in welcoming our 2019 incoming Pulmonary/Critical Care and Sleep Fellows! Pulmonary/Critical Care Frederick Jung, MD Medical School- Loyola University Chicago Stritch School of Medicine Residency- Tulane University School of Medicine New Orleans, LA Ryan Hyde, DO…
In our most recent Press Ganey patient satisfaction results, over 70 UF Health physicians scored in the top decile for patient satisfaction compared to peers nationwide. This is a huge accomplishment and evidence of the providers dedication and commitment to our patients.
“Assistant Professor of Medicine Ali Ataya, one of the clinic leaders said this disease most commonly affects women of ‘childbearing’ age. The rare disease LAM stands for lymphangioleiomyomatosis. “ https://mycbs4.com/news/local/uf-health-now-a-clinic-to-treat-rare-lung-disease …
Sarcoidosis is an inflammatory disease that can affect almost any organ in the body. It causes a person’s immune system, which normally protects the body from infection, to overreact and damage the body’s own tissues. The most notable feature of the disease is the development of small clusters f cells,…
The Division of Pulmonary, Critical Care, and Sleep Medicine is excited to announce that we are now an accredited LAM and Rare Lung Disease clinic site. This will be lead by Drs. Mark Brantly and Ali Ataya. For more information on LAM please visit: http://www.thelamfoundation.org/Newly-Diagnosed/Learning-About-Lam/About-LAM…
Please join the Division of Pulmonary, Critical Care and Sleep Medicine in congratulating Dr. Jorge Lascano and Dr. Hiren Mehta on their promotions to Clinical Associate Professor! …
University of Florida Health has been designated a member of the Pulmonary Fibrosis Foundation’s Care Center Network, making it one of just 60 medical centers nationwide with the highest level of expertise and resources for the treatment of interstitial lung disease. UF Health was one of 15 centers recently added to the network. The UF Health interstitial lung disease program serves a large geographic area in central and northern Florida, southern Georgia and southern Alabama. The closest member of the network is in Charleston, S.C., about 316 miles away. Borna Mehrad, M.D., a professor and chief of the UF College of Medicine’s division of pulmonary, critical care and sleep medicine, thanked the foundation and said the designation will help patients and physicians more quickly identify UF Health as a referral center for interstitial lung disease. Interstitial lung disease includes more than 200 distinct disorders, including idiopathic pulmonary fibrosis, which result in inflammation and scarring of lung tissues. “Patients with interstitial lung disease are often initially diagnosed as having pneumonia, asthma, or chronic obstructive pulmonary disease,” Mehrad said. “Eventually, when their symptoms do not respond to treatment, they are referred to a local pulmonary doctor. Our goal is to have those pulmonary doctors refer the patients to us as soon as possible, so they undergo the appropriate work-up to reach the correct diagnosis, are started on the right treatment and, if necessary, are evaluated for lung transplantation.” More than 40,000 people die from pulmonary fibrosis in the U.S. annually and more than 200,000 Americans live with the disease, the foundation said. About 50,000 new cases are diagnosed each year. Although there is no known cure for most of these diseases, many patients do well if they are appropriately diagnosed and treated. "As the leading resource for the pulmonary fibrosis community, the Pulmonary Fibrosis Foundation is committed to developing new tools and support to help ensure patients receive a swift and accurate diagnosis along with the highest quality of care," said Gregory P. Cosgrove, M.D., chief medical officer of the foundation. "The launch of our 15 new Care Center Network sites provides crucial resources for care along with an infrastructure that facilitates research toward a cure." Borna Mehrad, M.D., chief of the UF College of Medicine’s division of pulmonary, critical care and sleep medicine, talks to a patient recently at UF Health’s interstitial lung disease clinic. The Care Center Network fosters a multidisciplinary approach to delivering comprehensive patient care, the foundation said. Experts in pulmonary medicine, rheumatology, radiology and pathology are part of the care team at each medical center. Network facilities also foster research and patient education. Care Center Network sites “have experience and expertise in treating patients with fibrotic lung diseases and are dedicated to improving the lives of those living” with pulmonary fibrosis, the foundation said. Mehrad noted that patients whose diseases are managed by a group of physicians dedicated to interstitial lung disease respond much better. “It’s really important that these patients are seen by a group of lung doctors who specialize in these diseases, take care of them all the time, read about them, think about them and write about them,” he said.
The Division of Pulmonary, Critical Care & Sleep Medicine would like to congratulate Dr. Raju Reddy for being a recipient of the 2018 CTSI Clinical Pilot Award. Dr. Reddy’s research interest is in the mechanism of lung injury and he will be investigating “Molecular Signatures in Acute Respiratory Distress Syndrome:…
